COMMUNIQUÉS West-GlobeNewswire

Appendix 4C – Q2 FY25 Quarterly Cash Flow Report

24/01/2025 - 13:35

Highlights Topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February 2025 ATH434-201 trial in early-stage MSA completed in November 2024 Positive interim [...]

Director/PDMR Shareholding

24/01/2025 - 13:00

DXS INTERNATIONAL PLC (AQSE: DXSP) Notification of Director / PDMR Dealing DXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support [...]

Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.

24/01/2025 - 13:00

SHANNON, Ireland, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Irish medical device company Biomimetic Innovations Limited, an affiliate of PBC Biomed, today announced the execution of an exclusive license and distribution [...]

Novo Nordisk successfully completes phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity

24/01/2025 - 11:19

Bagsværd, Denmark, 24 January 2025 – Novo Nordisk today announced topline results from a phase 1b/2a clinical trial with amycretin, a unimolecular GLP-1 and amylin receptor agonist intended for once weekly subcutaneous [...]

Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference

24/01/2025 - 01:53

WARREN, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T [...]

Dermatology Group of Arkansas Welcomes a New Registered Nurse

24/01/2025 - 01:04

Shelby Brady joins Dermatology Group of Arkansas as an RN focused on skin health for patients in the Little Rock area LITTLE ROCK, Ark., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Dermatology Group of Arkansas is always seeking [...]

Ascentage Pharma Announces Pricing of U.S. Initial Public Offering

24/01/2025 - 00:41

ROCKVILLE, Md. and SUZHOU, China, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the pricing of its U.S. initial public offering of 7,325,000 American depositary shares (“ [...]

NADP Foundation Announces 2025 Grants to Advance Access to Oral Healthcare

23/01/2025 - 23:15

DALLAS, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The National Association of Dental Plans Foundation recently awarded a total of $99,000 to three innovative organizations focused on the advancement of access to oral health [...]

Impact BioMedical Inc. to Present at The Microcap Conference

23/01/2025 - 22:30

HOUSTON, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, today [...]

Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress

23/01/2025 - 22:05

Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress PARIS, France – January 23, 2025 – 10:05 PM CET – Abivax SA ( [...]

Vincerx Pharma, Inc. Announces Reverse Stock Split

23/01/2025 - 22:05

Vincerx’s Common Stock to Begin Trading on a Split-adjusted Basis on January 28, 2025 SAN MATEO, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to [...]

Intuitive Announces Fourth Quarter Earnings

23/01/2025 - 22:05

SUNNYVALE, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial [...]

Larimar Therapeutics Announces Dosing of Adolescents in Nomlabofusp Pediatric Pharmacokinetic Run-In Study for Patients with Friedreich’s Ataxia

23/01/2025 - 22:05

Adolescents receive a weight-based dose equivalent to the 50 mg adult dose Adolescents 12-17 years old who complete participation in the pharmacokinetic (PK) run-in study will be eligible to screen in the ongoing open [...]

Grant of Restricted Stock Units and Warrants to Employees in Genmab

23/01/2025 - 21:08

Company Announcement COPENHAGEN, Denmark; January 23, 2025 – Genmab A/S (Nasdaq: GMAB) announced today that the Board decided to grant 4,903 restricted stock units and 5,289 warrants to employees of the Company and the [...]

Tiziana Life Sciences Announces Positive Results in Treating Spinal Cord Injury With Nasal Anti-CD3

23/01/2025 - 21:00

NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]

MiNK Therapeutics Targets Immune Reconstitution to Combat Advanced Gastroesophageal Cancers with Novel Combination of Allo-iNKTs plus BOT/BAL at ASCO GI

23/01/2025 - 20:13

NEW YORK, Jan. 23, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf invariant natural killer T (iNKT) [...]

Vessl Prosthetics Secures Oversubscribed Pre-Seed Funding to Drive Innovation in Prosthetic Solutions

23/01/2025 - 19:00

LONDON, Ontario, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Vessl, a London-based startup specializing in advanced prosthetic systems, is proud to announce the successful completion of its first funding round, securing [...]

America’s Top 40 High School Scientists to Compete for $1.8 Million in Awards at Prestigious Regeneron Science Talent Search

23/01/2025 - 18:00

The Regeneron Science Talent Search Celebrates and Rewards Today’s Most Talented Young Minds Driving Innovation and Progress through Scientific Exploration TARRYTOWN, N.Y. and WASHINGTON, D.C., Jan. 23, 2025 (GLOBE [...]

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23

23/01/2025 - 17:00

HOUSTON, TX, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to invite investors to a webinar today, January 23, 2025, at 4:15 p.m. ET. The [...]